These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 10908959)

  • 21. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis.
    Takao H; Nojo T; Ohtomo K
    Acad Radiol; 2008 Apr; 15(4):462-71. PubMed ID: 18342771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance angiographic screening for asymptomatic intracranial aneurysms: the problem of false negatives: technical case report.
    Vanninen RL; Hernesniemi JA; Puranen MI; Ronkainen A
    Neurosurgery; 1996 Apr; 38(4):838-40; discussion 840-1. PubMed ID: 8692408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics and aneurysm formation.
    Schievink WI
    Neurosurg Clin N Am; 1998 Jul; 9(3):485-95. PubMed ID: 9668181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Magnetic resonance angiography of intracranial aneurysms: comparative study with cerebral angiography].
    Spotti AR; Lima EG ; Santos ML; Magalhães AC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-B):384-9. PubMed ID: 11460184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial aneurysms: current evidence and clinical practice.
    Vega C; Kwoon JV; Lavine SD
    Am Fam Physician; 2002 Aug; 66(4):601-8. PubMed ID: 12201551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease.
    Xu HW; Yu SQ; Mei CL; Li MH
    Stroke; 2011 Jan; 42(1):204-6. PubMed ID: 21164130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening and management of intracranial aneurisms in patients with autosomal dominant polycystic kidney disease].
    Flahault A; Knebelmann B; Nataf F; Trystram D; Grünfeld JP; Joly D
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S147-S153. PubMed ID: 28577737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.
    Zhou Z; Xu Y; Delcourt C; Shan J; Li Q; Xu J; Hackett ML
    Cerebrovasc Dis; 2017; 44(1-2):75-82. PubMed ID: 28502970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for intracranial aneurysms in high-risk relatives.
    Lindbloom EJ
    J Fam Pract; 2000 Feb; 49(2):184-5. PubMed ID: 10718699
    [No Abstract]   [Full Text] [Related]  

  • 31. Ruptured cerebral aneurysm not detected by magnetic resonance angiography in juvenile autosomal dominant polycystic kidney.
    Nakajima F; Shibahara N; Arai M; Ueda H; Katsuoka Y
    Int J Urol; 2000 Apr; 7(4):153-6. PubMed ID: 10810973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR angiography as a screening tool for intracranial aneurysms: feasibility, test characteristics, and interobserver agreement.
    Raaymakers TW; Buys PC; Verbeeten B; Ramos LM; Witkamp TD; Hulsmans FJ; Mali WP; Algra A; Bonsel GJ; Bossuyt PM; Vonk CM; Buskens E; Limburg M; van Gijn J; Gorissen A; Greebe P; Albrecht KW; Tulleken CA; Rinkel GJ
    AJR Am J Roentgenol; 1999 Dec; 173(6):1469-75. PubMed ID: 10584784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic decision and management of aneurysmal subarachnoid haemorrhage based on computed tomographic angiography.
    Dehdashti AR; Rufenacht DA; Delavelle J; Reverdin A; de Tribolet N
    Br J Neurosurg; 2003 Feb; 17(1):46-53. PubMed ID: 12779201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Flahault A; Joly D
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1242-1244. PubMed ID: 31217168
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors for the association of intracranial and aortic aneurysms.
    Miyazawa N; Akiyama I; Yamagata Z
    Acta Neurochir (Wien); 2007 Mar; 149(3):221-9; discussion 229. PubMed ID: 17273890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease.
    Huston J; Torres VE; Sulivan PP; Offord KP; Wiebers DO
    J Am Soc Nephrol; 1993 Jun; 3(12):1871-7. PubMed ID: 8338918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic subdural haematoma and arachnoid cyst in autosomal dominant polycystic kidney disease (ADPKD).
    Leung GK; Fan YW
    J Clin Neurosci; 2005 Sep; 12(7):817-9. PubMed ID: 16150597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid haemorrhage: a cohort study.
    Bor AS; Rinkel GJ; van Norden J; Wermer MJ
    Lancet Neurol; 2014 Apr; 13(4):385-92. PubMed ID: 24618352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.
    Flahault A; Trystram D; Nataf F; Fouchard M; Knebelmann B; Grünfeld JP; Joly D
    Kidney Int; 2018 Mar; 93(3):716-726. PubMed ID: 29061331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and surgical management of extracranial PICA aneurysms presenting through subarachnoid haemorrhage: Case report and review of the literature.
    Dammers R; Krisht AF; Partington S
    Clin Neurol Neurosurg; 2009 Nov; 111(9):758-61. PubMed ID: 19651470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.